RxDoctor Payments Data

Khanh Vu, MD

Family Medicine · Henderson, NCNPI 1679570717

Payments from drug & device makers

$8,883in general payments, 2019–2025

Across 496 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$823
  • Pfizer$740
  • AbbVie$704
  • GSK$542
  • Sanofi-aventis U.S. LLC$520
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$8,78199%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk102$1,790
AstraZeneca33$823
Pfizer47$740
AbbVie(2 entities)44$704
GSK39$542
Sanofi-aventis U.S. LLC32$520
Lilly USA, LLC22$376
Amgen31$374
Sanofi Pasteur Inc.9$212
Esperion Therapeutics, Inc.10$195
Medtronic1$181
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$142
Astellas Pharma US Inc6$121
Somnomed Inc.3$116
Recordati_rare_diseases_inc.1$112
Merck8$107
Ultragenyx Pharmaceutical Inc.4$98
E.r. Squibb & Sons, L.L.C.6$96
Corcept Therapeutics4$92
Bayer5$88
Innovation Technologies Inc1$84
Otsuka America Pharmaceutical, Inc.3$78
Mylan Specialty L.p.5$78
Johnson & Johnson5$75
Boehringer Ingelheim4$72
Abbott3$72
Aimmune Therapeutics, Inc.3$61
Teva Pharmaceuticals USA, Inc.4$56
Genentech USA, Inc.4$55
Novartis4$54
Amarin Pharma, Inc.4$51
Si-bone, Inc.1$47
Verona Pharma, Inc.2$42
Cranial Technologies, Inc2$40
Exact Sciences2$36
Xeris Pharmaceuticals, Inc.2$35
Cequr Corporation2$35
Dexcom, Inc.2$34
Baxter Healthcare1$33
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$31
Arbor Pharmaceuticals, Inc.2$30
Teleflex LLC1$27
Takeda Pharmaceuticals U.S.A., Inc.2$26
Global Blood Therapeutics, Inc.2$26
Corium, LLC1$23
Shield Therapeutics Inc1$23
Lupin Inc.2$22
Kyowa Kirin, Inc.1$22
Organon1$21
Hologic Sales And Service, LLC1$20
VBI Vaccine (delaware) Inc.1$18
Shire North American Group Inc1$17
Seqirus USA Inc1$17
Supernus Pharmaceuticals, Inc.1$16
Neotract Inc.1$15
Philips North America LLC1$15
Dynavax Technologies Corporation1$14
Mannkind Corporation1$13
Nestle Healthcare Nutrition Inc.1$12
Alkermes, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,883 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,426
Medicare patients
11
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$78,132
MounjaroTirzepatide56$73,574
EliquisApixaban57$47,115
JardianceEmpagliflozin25$23,833
XareltoRivaroxaban16$15,452
FarxigaDapagliflozin Propanediol22$15,102
RybelsusSemaglutide11$14,582
LinzessLinaclotide16$12,667
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,999
Tresiba Flextouch U-100Insulin Degludec15$7,365
SymbicortBudesonide/Formoterol Fumarate13$4,771
Breo ElliptaFluticasone/Vilanterol12$4,766
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,303
Atorvastatin Calcium270$3,223
ArexvyRsvpref3 Antigen/As01e/Pf11$3,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,790$92,71492 claims
Lilly USA, LLCMounjaro$376$73,57456 claims
PfizerEliquis$740$47,11557 claims
Boehringer IngelheimJardiance$72$23,83325 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Arexvy$542$20,26151 claims
AstraZenecaFarxiga, Symbicort$823$19,87335 claims
Johnson & JohnsonXarelto$75$15,45216 claims
AbbVieLinzess$704$12,66716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Henderson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →